LIM kinase inhibitor: A novel pharmacological strategy in the treatment of mixed symptoms in mixed LUTS?

被引:0
作者
Yu, Q. [1 ]
Cen, P. [1 ]
Lan, H. [1 ]
Zhou, X. [1 ]
Huang, R. [1 ]
Zeng, G. [1 ]
机构
[1] Guangzhou Med Univ, Dept Urol, Affiliated Hosp 1, Guangzhou, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A1013
引用
收藏
页码:S2109 / S2109
页数:1
相关论文
共 50 条
[31]   Novel trends in mixed oxide electrodes for wastewater treatment [J].
Castillo-Cabrera, G. Xavier ;
Espinoza-Montero, Patricio J. .
CURRENT OPINION IN ELECTROCHEMISTRY, 2024, 44
[32]   Rituximab: A novel treatment for type II mixed cryoglobulinemia [J].
De Vita, S ;
Zaja, F ;
De Marchi, G ;
Damiani, D ;
Sacco, S ;
Mazzaro, C ;
Fanin, R ;
Ferraccioli, G .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 :84-84
[33]   Leptin - A novel pharmacological agent for treatment of women with overactive bladder symptoms? [J].
Wuntakal, Rekha ;
Sharma, Sunita ;
Kaler, Mandeep ;
Hollingworth, Tony .
MEDICAL HYPOTHESES, 2012, 79 (06) :856-857
[34]   Phase I and pharmacological study of the novel aurora kinase inhibitor AZD1152. [J].
Schellens, J. H. ;
Boss, D. ;
Witteveen, P. O. ;
Zandvliet, A. ;
Beijnen, J. H. ;
Voogel-Fuchs, M. ;
Morris, C. ;
Wilson, D. ;
Voest, E. E. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :122S-122S
[35]   Novel Class of LIM-Kinase 2 Inhibitors for the Treatment of Ocular Hypertension and Associated Glaucoma [J].
Harrison, Bryce A. ;
Whitlock, N. Andrew ;
Voronkov, Michael V. ;
Almstead, Zheng Y. ;
Gu, Kun-jian ;
Mabon, Ross ;
Gardyan, Michael ;
Hamman, Brian D. ;
Allen, Jason ;
Gopinathan, Suma ;
McKnight, Beth ;
Crist, Mike ;
Zhang, Yulian ;
Liu, Ying ;
Courtney, Lawrence F. ;
Key, Billie ;
Zhou, Julia ;
Patel, Nita ;
Yates, Phil W. ;
Liu, Qingyun ;
Wilson, Alan G. E. ;
Kimball, S. David ;
Crosson, Craig E. ;
Rice, Dennis S. ;
Rawlins, David B. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (21) :6515-6518
[36]   A SYSTEMATIC REVIEW AND MIXED TREATMENT COMPARISON (MTC) OF THE EFFICACY OF PHARMACOLOGICAL TREATMENTS FOR FIBROMYALGIA [J].
Choy, E. ;
Marshall, D. ;
Gabriel, Z. ;
Mitchell, S. ;
Gylee, E. ;
Dakin, H. A. .
VALUE IN HEALTH, 2009, 12 (07) :A434-A434
[37]   Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase [J].
Goodfellow, Val S. ;
Loweth, Colin J. ;
Ravula, Satheesh B. ;
Wiemann, Torsten ;
Thong Nguyen ;
Xu, Yang ;
Todd, Daniel E. ;
Sheppard, David ;
Pollack, Scott ;
Polesskaya, Oksana ;
Marker, Daniel F. ;
Dewhurst, Stephen ;
Gelbard, Harris A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (20) :8032-8048
[38]   A Novel Approach for Pipeline Generation Using a Mixed GA and Tree Strategy [J].
Wang, Jiaoyang ;
Xiahou, Xiaer ;
Lin, Yuhao ;
Liu, Yaozhang ;
Han, Zizhe ;
Song, Yuhao .
JOURNAL OF CONSTRUCTION ENGINEERING AND MANAGEMENT, 2025, 151 (09)
[39]   Novel mixed-criticality reliability scheduling strategy and schedulability test [J].
Jing W. ;
Huo S. ;
Chen G. ;
Liu Y. .
Xi'an Dianzi Keji Daxue Xuebao/Journal of Xidian University, 2016, 43 (06) :158-163
[40]   Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor [J].
Sweeney, WE ;
Chen, YG ;
Nakanishi, K ;
Frost, P ;
Avner, ED .
KIDNEY INTERNATIONAL, 2000, 57 (01) :33-40